Back to today’s briefing

Story perspectives

Facelift Demand Rises as GLP-1 Meds Cause Skin Issues

5/22/2025

26 6

Summary

Story summary

Facelift requests are soaring as Dr. Julius Few reveals that GLP-1 medications, such as Ozempic, are leading to excess skin and reduced elasticity. In response, his groundbreaking study on a retinol-peptide serum demonstrates promising results, enhancing skin firmness for those affected. This innovative approach could be a game-changer for restoring skin vitality.

1 of 1

Story summary

Facelift requests are soaring as Dr. Julius Few reveals that GLP-1 medications, such as Ozempic, are leading to excess skin and reduced elasticity. In response, his groundbreaking study on a retinol-peptide serum demonstrates promising results, enhancing skin firmness for those affected. This innovative approach could be a game-changer for restoring skin vitality.